Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: CB8832C96B32EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 in Global, including the following market information:

Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

ETBX-011 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 include Akshaya Bio Inc., Celgene Corporation, Etubics Corporation, OSE Immunotherapeutics and Vaxon Biotech, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Segment Percentages, by Type, 2021 (%)

• ETBX-011
• Vbx-016
• OSE-2101
• GI-6207
• Others

Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Segment Percentages, by Application, 2021 (%)

• Metastatic Breast Cancer
• Metastatic Pancreatic Cancer
• Peritoneal Tumor
• Others

Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Akshaya Bio Inc.
• Celgene Corporation
• Etubics Corporation
• OSE Immunotherapeutics
• Vaxon Biotech

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 5 OVERALL MARKET SIZE

2.1 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size: 2021 VS 2028
2.2 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Players in Global Market
3.2 Top Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Companies Ranked by Revenue
3.3 Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue by Companies
3.4 Top 3 and Top 5 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Companies in Global Market, by Revenue in 2021
3.5 Global Companies Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Product Type
3.6 Tier 1, Tier 2 and Tier 3 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Players in Global Market
  3.6.1 List of Global Tier 1 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Companies
  3.6.2 List of Global Tier 2 and Tier 3 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size Markets, 2021 & 2028
  4.1.2 ETBX-011
  4.1.3 Vbx-016
  4.1.4 OSE-2101
  4.1.5 GI-6207
  4.1.6 Others
4.2 By Type - Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue & Forecasts
  4.2.1 By Type - Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, 2017-2022
  4.2.2 By Type - Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, 2023-2028
  4.2.3 By Type - Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2021 & 2028
  5.1.2 Metastatic Breast Cancer
  5.1.3 Metastatic Pancreatic Cancer
  5.1.4 Peritoneal Tumor
  5.1.5 Others
5.2 By Application - Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue & Forecasts
  5.2.1 By Application - Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, 2017-2022
  5.2.2 By Application - Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, 2023-2028
  5.2.3 By Application - Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2021 & 2028
6.2 By Region - Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue & Forecasts
  6.2.1 By Region - Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, 2017-2022
  6.2.2 By Region - Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, 2023-2028
  6.2.3 By Region - Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, 2017-2028
  6.3.2 US Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2017-2028
  6.3.3 Canada Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2017-2028
  6.3.4 Mexico Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, 2017-2028
  6.4.2 Germany Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2017-2028
  6.4.3 France Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2017-2028
  6.4.4 U.K. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2017-2028
  6.4.5 Italy Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2017-2028
  6.4.6 Russia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2017-2028
  6.4.7 Nordic Countries Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2017-2028
  6.4.8 Benelux Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, 2017-2028
  6.5.2 China Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2017-2028
  6.5.3 Japan Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2017-2028
  6.5.4 South Korea Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2017-2028
  6.5.5 Southeast Asia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2017-2028
  6.5.6 India Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, 2017-2028
  6.6.2 Brazil Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2017-2028
  6.6.3 Argentina Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, 2017-2028
  6.7.2 Turkey Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2017-2028
  6.7.3 Israel Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2017-2028
  6.7.4 Saudi Arabia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2017-2028
  6.7.5 UAE Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Akshaya Bio Inc.
  7.1.1 Akshaya Bio Inc. Corporate Summary
  7.1.2 Akshaya Bio Inc. Business Overview
  7.1.3 Akshaya Bio Inc. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Major Product Offerings
  7.1.4 Akshaya Bio Inc. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue in Global Market (2017-2022)
  7.1.5 Akshaya Bio Inc. Key News
7.2 Celgene Corporation
  7.2.1 Celgene Corporation Corporate Summary
  7.2.2 Celgene Corporation Business Overview
  7.2.3 Celgene Corporation Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Major Product Offerings
  7.2.4 Celgene Corporation Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue in Global Market (2017-2022)
  7.2.5 Celgene Corporation Key News
7.3 Etubics Corporation
  7.3.1 Etubics Corporation Corporate Summary
  7.3.2 Etubics Corporation Business Overview
  7.3.3 Etubics Corporation Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Major Product Offerings
  7.3.4 Etubics Corporation Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue in Global Market (2017-2022)
  7.3.5 Etubics Corporation Key News
7.4 OSE Immunotherapeutics
  7.4.1 OSE Immunotherapeutics Corporate Summary
  7.4.2 OSE Immunotherapeutics Business Overview
  7.4.3 OSE Immunotherapeutics Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Major Product Offerings
  7.4.4 OSE Immunotherapeutics Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue in Global Market (2017-2022)
  7.4.5 OSE Immunotherapeutics Key News
7.5 Vaxon Biotech
  7.5.1 Vaxon Biotech Corporate Summary
  7.5.2 Vaxon Biotech Business Overview
  7.5.3 Vaxon Biotech Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Major Product Offerings
  7.5.4 Vaxon Biotech Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue in Global Market (2017-2022)
  7.5.5 Vaxon Biotech Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Opportunities & Trends in Global Market
Table 2. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Drivers in Global Market
Table 3. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Restraints in Global Market
Table 4. Key Players of Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 in Global Market
Table 5. Top Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Share by Companies, 2017-2022
Table 8. Global Companies Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Product Type
Table 9. List of Global Tier 1 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2023-2028
Table 30. Akshaya Bio Inc. Corporate Summary
Table 31. Akshaya Bio Inc. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Product Offerings
Table 32. Akshaya Bio Inc. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue (US$, Mn), (2017-2022)
Table 33. Celgene Corporation Corporate Summary
Table 34. Celgene Corporation Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Product Offerings
Table 35. Celgene Corporation Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue (US$, Mn), (2017-2022)
Table 36. Etubics Corporation Corporate Summary
Table 37. Etubics Corporation Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Product Offerings
Table 38. Etubics Corporation Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue (US$, Mn), (2017-2022)
Table 39. OSE Immunotherapeutics Corporate Summary
Table 40. OSE Immunotherapeutics Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Product Offerings
Table 41. OSE Immunotherapeutics Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue (US$, Mn), (2017-2022)
Table 42. Vaxon Biotech Corporate Summary
Table 43. Vaxon Biotech Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Product Offerings
Table 44. Vaxon Biotech Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Segment by Type in 2021
Figure 2. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Segment by Application in 2021
Figure 3. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue in 2021
Figure 8. By Type - Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share, 2017-2028
Figure 9. By Application - Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share, 2017-2028
Figure 10. By Region - Global Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share, 2017-2028
Figure 11. By Country - North America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share, 2017-2028
Figure 12. US Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share, 2017-2028
Figure 16. Germany Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2028
Figure 17. France Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share, 2017-2028
Figure 24. China Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2028
Figure 28. India Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share, 2017-2028
Figure 30. Brazil Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Market Share, 2017-2028
Figure 33. Turkey Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue, (US$, Mn), 2017-2028
Figure 37. Akshaya Bio Inc. Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Celgene Corporation Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Etubics Corporation Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. OSE Immunotherapeutics Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Vaxon Biotech Carcinoembryonic Antigen Related Cell Adhesion Molecule 5 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)